JP2024538730A5 - - Google Patents

Info

Publication number
JP2024538730A5
JP2024538730A5 JP2024521109A JP2024521109A JP2024538730A5 JP 2024538730 A5 JP2024538730 A5 JP 2024538730A5 JP 2024521109 A JP2024521109 A JP 2024521109A JP 2024521109 A JP2024521109 A JP 2024521109A JP 2024538730 A5 JP2024538730 A5 JP 2024538730A5
Authority
JP
Japan
Prior art keywords
methylene
substituted
pharmaceutical composition
atoms
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521109A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077702 external-priority patent/WO2023060200A1/en
Publication of JP2024538730A publication Critical patent/JP2024538730A/ja
Publication of JP2024538730A5 publication Critical patent/JP2024538730A5/ja
Pending legal-status Critical Current

Links

JP2024521109A 2021-10-07 2022-10-06 がん及び腫瘍を治療するための方法 Pending JP2024538730A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163253332P 2021-10-07 2021-10-07
US63/253,332 2021-10-07
PCT/US2022/077702 WO2023060200A1 (en) 2021-10-07 2022-10-06 Methods for treating cancers and tumors

Publications (2)

Publication Number Publication Date
JP2024538730A JP2024538730A (ja) 2024-10-23
JP2024538730A5 true JP2024538730A5 (cg-RX-API-DMAC7.html) 2025-10-15

Family

ID=85804784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521109A Pending JP2024538730A (ja) 2021-10-07 2022-10-06 がん及び腫瘍を治療するための方法

Country Status (6)

Country Link
US (1) US20240408082A1 (cg-RX-API-DMAC7.html)
EP (1) EP4412613A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024538730A (cg-RX-API-DMAC7.html)
CN (1) CN118369101A (cg-RX-API-DMAC7.html)
CA (1) CA3234699A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023060200A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109475524A (zh) 2016-06-06 2019-03-15 万春药业公司 用于减少中性粒细胞减少症的组合物和方法
KR20190109479A (ko) 2017-02-01 2019-09-25 비욘드스프링 파마수티컬스, 인코포레이티드. 호중구감소증의 감소 방법
EP4319751A4 (en) 2021-04-09 2025-02-26 Beyondspring Pharmaceuticals, Inc. THERAPEUTIC COMPOSITIONS AND METHODS FOR THE TREATING OF TUMORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0506655A (pt) * 2004-02-04 2007-05-08 Nereus Pharmaceuticals Inc dehidrofenilahistinas e seus análogos, e sìntese de dehidrofenilahistinas e seus análogos
HK1249052A1 (zh) * 2015-03-06 2018-10-26 BeyondSpring Pharmaceuticals Inc. 治疗与ras突变相关的癌症的方法
KR20210047309A (ko) * 2018-08-16 2021-04-29 비욘드스프링 파마수티컬스, 인코포레이티드. 면역 반응을 자극하기 위한 방법 및 조성물
AU2019378779A1 (en) * 2018-11-14 2021-06-03 Beyondspring Pharmaceuticals, Inc. Methods of treating cancer using tubulin binding agents

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
CN105008343B (zh) 作为选择性雌激素受体降解剂的苯并噻吩衍生物及其组合物
CN101142198B (zh) 用于治疗疾病的异*唑坎布雷它斯丁衍生物
WO2020065453A1 (en) Process of manufacture of a compound for inhibiting the activity of shp2
JP2024513505A5 (cg-RX-API-DMAC7.html)
JP2019515884A5 (cg-RX-API-DMAC7.html)
JP2006523216A5 (cg-RX-API-DMAC7.html)
JP2007511504A5 (cg-RX-API-DMAC7.html)
JP2006511534A5 (cg-RX-API-DMAC7.html)
JP2002525329A5 (cg-RX-API-DMAC7.html)
JP2007520452A5 (cg-RX-API-DMAC7.html)
JP2022521081A (ja) Hbv感染若しくはhbv誘導性疾患の治療において有用なアミド誘導体
EP2455081A1 (en) S1P1 receptor agonists for use in the treatment of crohn's disease
JP2007505044A5 (cg-RX-API-DMAC7.html)
JP2021536472A5 (cg-RX-API-DMAC7.html)
JP2005501825A5 (cg-RX-API-DMAC7.html)
JP2022502378A5 (cg-RX-API-DMAC7.html)
JP2025509830A5 (cg-RX-API-DMAC7.html)
JP2003532724A5 (cg-RX-API-DMAC7.html)
JP2023541040A5 (cg-RX-API-DMAC7.html)
JP2023524274A5 (cg-RX-API-DMAC7.html)
WO2021062168A1 (en) Synthetic sphingolipid inspired molecules with heteroaromatic appendages, methods of their synthesis and methods of treatment
JP2005503411A5 (cg-RX-API-DMAC7.html)
CN102190656B (zh) 含有五元杂环的噁唑烷酮抗菌素
CN114075123B (zh) 苄胺类衍生物及其制备方法与用途